Literature DB >> 15744077

Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency.

Koki Wada1, Hidetoshi Arima, Toshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama.   

Abstract

To improve in vitro gene transfer efficiency and/or achieve cell-specific gene delivery of polyamidoamine (PAMAM) starburst dendrimer (generation 2, G2) conjugate with alpha-cyclodextrin (alpha-CDE conjugate (G2)), we prepared alpha-CDE conjugate bearing galactose (Gal-alpha-CDE conjugates) with the various degrees of substitution of the galactose moiety (DSG) as a novel non-viral vector. The agarose gel electrophoretic studies revealed that Gal-alpha-CDE conjugates formed complexes with plasmid DNA (pDNA) and protected the degradation of pDNA by DNase I, but these effects impaired as the DSG value increased. Dendrimer and alpha-CDE conjugate exerted pDNA condensation through the complexation, but Gal-alpha-CDE conjugates did not. Gal-alpha-CDE conjugate (DSG 4) was found to have much higher gene transfer activity than dendrimer, alpha-CDE conjugate and Gal-alpha-CDE conjugates (DSG 8, 15) in HepG2, NIH3T3 and A549 cells, which are independent of the expression of the asialoglycoprotein receptor. Transfection activity of Gal-alpha-CDE conjugate (DSG 4) was insensitive to the existence of competitors (asialofetuin and galactose) and serum. In addition, no cytotoxicity after transfection of the complex of pDNA with Gal-alpha-CDE conjugate (DSG 4) was observed. These results suggest the potential use of Gal-alpha-CDE conjugate (DSG 4) as a non-viral vector in various cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744077     DOI: 10.1248/bpb.28.500

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

Review 1.  Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

Authors:  Prashant Kesharwani; Arun K Iyer
Journal:  Drug Discov Today       Date:  2014-12-31       Impact factor: 7.851

2.  In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes.

Authors:  Keiichi Motoyama; Yoshihiro Nakashima; Yukihiko Aramaki; Fumitoshi Hirayama; Kaneto Uekama; Hidetoshi Arima
Journal:  J Drug Deliv       Date:  2010-12-09

3.  Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama
Journal:  Sensors (Basel)       Date:  2009-08-17       Impact factor: 3.576

Review 4.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

Review 5.  Cyclodextrins in non-viral gene delivery.

Authors:  Wing-Fu Lai
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

Review 6.  Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers.

Authors:  Hidetoshi Arima
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

7.  Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-30

8.  Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceutics       Date:  2012-02-01       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.